Macrocyclic quinazole derivatives and their use as MTKI

Details for Australian Patent Application No. 2005313350 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Embrechts, Werner Constant Johan; Poncelet, Virginie Sophie; Willems, Marc; Storck, Pierre Henri; Ten Holte, Peter; Papanikos, Alexandra; Freyne, Eddy Jean Edgard

Agent Shelston IP

Pub. Number AU-B-2005313350

PCT Pub. Number WO2006/061417

Priority 60/634,228 08.12.04 US; 04106383.5 08.12.04 EP

Filing date 8 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 31 May 2012

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 273/00 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/061417 Priority application(s): WO2006/061417

31 May 2012 Application Accepted

  Published as AU-B-2005313350

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005313353-Pressure cooker lid

2005313348-2,4 (4,6) pyrimidine derivatives